The Ministry of Food and Drug Safety (MFDS) announced that will be operating a ' 2024 Big Tech Company Regulatory Innovation Program’ again this year to provide continuous regulatory support to domestic digital medical device companies.

Last year, the MFDS identified the exact needs of the industry through the Big Tech Company Regulatory Innovation Program and selected 5 regulatory improvement tasks in the field of AI medical devices for regulatory improvement, and this year, the program has been expanded to include not only AI medical devices but also digital medical devices and increased the number of participating companies.

In addition to the Big tech companies that have previously